As big blockbusterssuchas Pfizer’s Lipitor go off patent, the industry is about to lose tens ofbillions of dollars in revenues to genericsmanufacturers.
On the other end of the spectrum, the lack of bigblockbusters suggests that PE-backed companies with the financial resources to wait out the market will do just that, if it means a better result for their sponsors down the road.